Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice

scientific article published on 01 November 1997

Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9366389

P2093author name stringGajewski TF
Gruber MM
Kranz DM
Rund LA
Fallarino F
Manning TC
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)4665-4675
P577publication date1997-11-01
P1433published inJournal of ImmunologyQ3521441
P1476titleAntigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice
P478volume159

Reverse relations

cites work (P2860)
Q36927352Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
Q36851775B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Q36179184CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection
Q35408974CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage
Q34100049Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors
Q34099738Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor
Q40944056Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Q34160808Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules
Q39172481The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
Q38704192Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy

Search more.